Burning Rock Biotech (BNR) Competitors $8.91 +0.31 (+3.60%) Closing price 03:59 PM EasternExtended Trading$8.82 -0.10 (-1.07%) As of 04:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BNR vs. LFMD, VMD, XGN, DCGO, CORBF, NAKA, EUDA, QIPT, SERA, and KDLYShould you be buying Burning Rock Biotech stock or one of its competitors? The main competitors of Burning Rock Biotech include LifeMD (LFMD), Viemed Healthcare (VMD), Exagen (XGN), DocGo (DCGO), Global Cord Blood (CORBF), KindlyMD (NAKA), EUDA Health (EUDA), Quipt Home Medical (QIPT), Sera Prognostics (SERA), and Kindly MD (KDLY). These companies are all part of the "healthcare" industry. Burning Rock Biotech vs. Its Competitors LifeMD Viemed Healthcare Exagen DocGo Global Cord Blood KindlyMD EUDA Health Quipt Home Medical Sera Prognostics Kindly MD LifeMD (NASDAQ:LFMD) and Burning Rock Biotech (NASDAQ:BNR) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, risk, media sentiment, institutional ownership, earnings and profitability. Is LFMD or BNR more profitable? LifeMD has a net margin of -2.41% compared to Burning Rock Biotech's net margin of -45.41%. LifeMD's return on equity of 0.00% beat Burning Rock Biotech's return on equity.Company Net Margins Return on Equity Return on Assets LifeMD-2.41% N/A -8.11% Burning Rock Biotech -45.41%-38.33%-25.34% Which has more volatility & risk, LFMD or BNR? LifeMD has a beta of 1.72, indicating that its stock price is 72% more volatile than the S&P 500. Comparatively, Burning Rock Biotech has a beta of 0.83, indicating that its stock price is 17% less volatile than the S&P 500. Which has higher valuation and earnings, LFMD or BNR? LifeMD has higher revenue and earnings than Burning Rock Biotech. LifeMD is trading at a lower price-to-earnings ratio than Burning Rock Biotech, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLifeMD$212.45M1.45-$18.88M-$0.21-30.95Burning Rock Biotech$70.67M1.36-$47.49M-$1.89-4.71 Does the media prefer LFMD or BNR? In the previous week, LifeMD had 6 more articles in the media than Burning Rock Biotech. MarketBeat recorded 8 mentions for LifeMD and 2 mentions for Burning Rock Biotech. Burning Rock Biotech's average media sentiment score of 1.08 beat LifeMD's score of 0.13 indicating that Burning Rock Biotech is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment LifeMD 0 Very Positive mention(s) 0 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Burning Rock Biotech 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders & institutionals hold more shares of LFMD or BNR? 35.5% of LifeMD shares are held by institutional investors. Comparatively, 30.0% of Burning Rock Biotech shares are held by institutional investors. 18.4% of LifeMD shares are held by insiders. Comparatively, 30.3% of Burning Rock Biotech shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Do analysts prefer LFMD or BNR? LifeMD currently has a consensus target price of $13.17, suggesting a potential upside of 102.56%. Given LifeMD's stronger consensus rating and higher possible upside, equities analysts plainly believe LifeMD is more favorable than Burning Rock Biotech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score LifeMD 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 3.00Burning Rock Biotech 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryLifeMD beats Burning Rock Biotech on 14 of the 17 factors compared between the two stocks. Get Burning Rock Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for BNR and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BNR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BNR vs. The Competition Export to ExcelMetricBurning Rock BiotechTechnology Services IndustryBusiness SectorNASDAQ ExchangeMarket Cap$92.55M$2.67B$26.26B$9.75BDividend YieldN/A1.57%2.78%4.07%P/E Ratio-4.7123.5428.3126.09Price / Sales1.3638.641,001.83120.66Price / CashN/A43.2326.4559.08Price / Book1.216.996.146.67Net Income-$47.49M$34.86M$197.87M$265.43M7 Day Performance-5.11%4.29%11.86%3.11%1 Month Performance31.03%-3.45%4.19%0.39%1 Year Performance53.09%54.18%44.71%18.52% Burning Rock Biotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BNRBurning Rock Biotech0.2762 of 5 stars$8.91+3.6%N/A+43.3%$92.55M$70.67M-4.711,390News CoveragePositive NewsUpcoming EarningsGap UpLFMDLifeMD2.5428 of 5 stars$6.51+1.2%$12.86+97.5%+13.6%$304.89M$212.45M-31.00230VMDViemed Healthcare1.0967 of 5 stars$6.92+0.4%N/A-4.1%$267.23M$224.26M20.351,179Positive NewsXGNExagen3.7809 of 5 stars$9.75+2.7%$11.25+15.4%+215.7%$208.82M$55.64M-10.96220Positive NewsDCGODocGo2.0984 of 5 stars$1.68+3.7%$3.56+111.9%-55.9%$158.45M$616.55M-8.844,407CORBFGlobal Cord BloodN/A$1.25+127.3%N/A+33.3%$151.94M$196.12M0.001,200NAKAKindlyMDN/A$12.02-12.1%N/AN/A$103.17M$2.72M-13.98N/ANews CoverageGap UpEUDAEUDA Health0.4475 of 5 stars$2.64+3.9%N/A-41.1%$94.38M$4.01M0.002News CoverageGap UpQIPTQuipt Home Medical1.9036 of 5 stars$2.26+10.8%$2.85+26.1%-8.7%$88.63M$245.91M-9.421,200News CoverageSERASera Prognostics1.2496 of 5 stars$2.38+5.8%N/A-64.5%$84.76M$80K-2.80120Positive NewsGap UpKDLYKindly MDN/A$13.67-9.0%N/A+511.3%$82.32M$2.47M-17.75N/APositive NewsGap Down Related Companies and Tools Related Companies LifeMD Competitors Viemed Healthcare Competitors Exagen Competitors DocGo Competitors Global Cord Blood Competitors KindlyMD Competitors EUDA Health Competitors Quipt Home Medical Competitors Sera Prognostics Competitors Kindly MD Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BNR) was last updated on 8/26/2025 by MarketBeat.com Staff From Our PartnersFed Decision Warning: How to Protect Your Wealth Before September 30th On September 17th, the Fed faces an impossible choice—and Wall Street insiders are already preparing for the...American Alternative | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredCover all your expenses with just $118,000 invested?Generate up to $5,000/month with 10X less money? That's what every financial advisor tells you. But I just ...Investors Alley | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Burning Rock Biotech Limited Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Burning Rock Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access